Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA approves vagus nerve stimulation trial for anxiety disorders

Feb. 5, 2001

Changes to Exelon product labeling announced by Novartis

Feb. 5, 2001

Neuron Therapeutics begins phase I trial with novel stroke therapy

Feb. 1, 2001

Pherin cleared to begin clinical trials of antianxiety compound

Feb. 1, 2001

CytRx and University of Cincinnati to investigate CRL-5861 for muscular dystrophy

Feb. 1, 2001

Potential Rx for neuropathic pain enters U.S. phase II trials

Jan. 31, 2001

Organon licenses Cortex's Ampakines for depression

Jan. 31, 2001

Recent patent covers Lilly's new muscarinic agents

Jan. 31, 2001

Lilly claims new modulators of metabotropic glutamate receptors and their uses

Jan. 31, 2001

Middle-aged women may reduce stroke risk by consuming more fish

Jan. 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...